Inhibrx Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-4.65-4.56-9.46-6.76
Price/Sales ratio
437.577.152.582.51
Earnings per Share (EPS)
$-4.94$-5.04$-2.43$-3.4

Historical Multiples (2016 – 2023)

2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-91.19-30.54-17.92-14.67-11.01-20.30-6.80-7.420.14-14.67
Price/Sales ratio
113.1174.7074.4782.9365.02232.96453.74994.96125.3082.93
Price/Book Value ratio
-81.55-20.64-9.69-8.0511.0331.6817.0241.161.30-8.05
Price/Cash Flow ratio
-41.64-31.67-24.19-23.50-17.36-20.66-8.57-9.26-1.11-23.50
Price/Free Cash Flow ratio
-41.15-29.55-22.78-22.25-16.88-20.44-8.52-9.04-1.01-22.25
Price/Earnings Growth ratio
N/A-0.15-0.25-0.64-0.090.72-0.09-0.17-0.00-0.64
Dividend Yield
N/A0.23%0.14%N/AN/AN/AN/AN/A5.66%N/A
Profitability Indicator Ratios
Gross Profit Margin
-154.86%-220.88%-346.05%-426.85%-473.82%62.27%-30.67%33.83%34.65%-426.85%
Operating Profit Margin
-182.18%-248.15%-393.50%-480.74%-526.56%-1074.58%-5928.23%-12178.94%-21326.93%-526.56%
Pretax Profit Margin
-193.26%-274.59%-412.33%-555.39%-590.52%-1147.59%-6667.72%-13318%94778.83%-555.39%
Net Profit Margin
-124.02%-244.55%-415.50%-565.27%-590.54%-1147.62%-6667.86%-13408.94%94684.71%-565.27%
Effective Tax Rate
35.82%-1.14%-0.31%-1.77%-0.00%-0.00%-0.00%-0.00%0.01%-1.77%
Return on Assets
-38.87%-112.73%-312.12%-194.04%-52.62%-54.34%-49.92%-78.39%737.69%-194.04%
Return On Equity
89.42%67.57%54.06%54.93%-100.21%-156.09%-250.14%-554.81%1450.04%54.93%
Return on Capital Employed
-75.95%-236.94%476.16%-738.53%-60.03%-59.81%-49.03%-87.13%-207.21%-738.53%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A4.20N/AN/AN/A4.704.20
Quick Ratio
3.861.610.200.608.326.2310.185.454.700.60
Cash ratio
3.791.510.120.564.095.849.934.934.450.56
Days of Sales Outstanding
N/A31.9533.5817.5817.5244.9743.06157.7695.7717.58
Days of Inventory outstanding
N/A14.2925.2124.43-642.04-119.22-32.96-3.55KN/AN/A
Operating Cycle
N/A46.2458.7942.01-624.51-74.2410.10-3.39K95.7742.01
Days of Payables Outstanding
3.5811.0871.2423.7366.831.23K556.992.54K3.98K23.73
Cash Conversion Cycle
-3.5835.15-12.4518.28-691.35-1.31K-546.88-5.94K-3.88K-691.35
Debt Ratios
Debt Ratio
0.880.850.951.570.260.470.700.67N/A0.26
Debt Equity Ratio
-2.04-0.50-0.16-0.440.491.373.514.80N/A-0.44
Long-term Debt to Capitalization
2.70-0.49-0.06-0.650.320.570.770.82N/A-0.65
Total Debt to Capitalization
1.95-1.03-0.19-0.800.330.570.770.82N/A-0.80
Interest Coverage Ratio
N/AN/AN/AN/A-6.23N/AN/AN/A-17.03-6.23
Cash Flow to Debt Ratio
-0.95-1.27-2.43-0.76-1.28-1.11-0.56-0.92N/A-0.76
Company Equity Multiplier
-2.30-0.59-0.17-0.281.902.875.017.071.24-0.28
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.71-2.35-3.07-3.52-3.74-11.27-52.93-107.39-119.67-3.74
Free Cash Flow / Operating Cash Flow Ratio
1.011.071.061.051.021.011.001.021.021.02
Cash Flow Coverage Ratio
-0.95-1.27-2.43-0.76-1.28-1.11-0.56-0.92N/A-0.76
Short Term Coverage Ratio
-4.25-3.62-3.89-6.87-31.91-47.98-61.98-93.70N/A-6.87
Dividend Payout Ratio
N/A-7.07%-2.65%N/AN/AN/AN/AN/AN/AN/A